Device malfunctions during routine maintenance are reportable -- FDA warning letter to Zoll.
This article was originally published in The Gray Sheet
Executive Summary
DEVICE MALFUNCTIONS DURING ROUTINE MAINTENANCE ARE REPORTABLE, FDA SAYS in a Nov. 21 warning letter to Zoll Medical. The warning letter, which follows an inspection conducted in September and October, cites two specific instances -- one in which a PD 1200 external defibrillator discharged when only one of the discharge buttons was pressed, and another in which a PD 1600 defibrillator shut down after three discharges with good batteries. Both events occurred during routine maintenance of the device and should have been reported because a reoccurrence "would be likely to cause or contribute to a death or serious injury," FDA says.
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.